It is thought that elevated serum FGF21 levels in obese people reflect the existence of fatty liver, and FGF21 may be a biomarker of hepatic lipid accumulation in obesity (45). The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.